For condition: Atopic Dermatitis
For condition: Eczema – Atopic Dermatitis
Research Study for Moderate to Severe Atopic Dermatitis (40 Weeks)
Study Summary
Who Can Participate?
Adult males and females aged ≥ 18 to ≤ 75 years with atopic dermatitis (AD), may be eligible.
Inclusion Criteria:
-
-
- Diagnosis of atopic dermatitis and onset of symptoms for at least 1 year
- Moderate to severe AD, with a body surface area (BSA) involvement of ≥ 10% (i.e. equal to 10 palm prints on your body)
- Disease that is not adequately controlled with topical prescription therapies or when those therapies are not advisable
- Has been using an emollient daily for at least 1 week, and agrees to continue using that same emollient throughout the study
-
Participant Info:
-
-
- No cost to participate or receive study treatment
- Regular visits with study doctors who are familiar with treating AD
- Will receive the investigational medication (active study drug) or placebo injected under your skin
- Reimbursement for study-related expenses may be provided
-
How Long Will The Study Last?
-
-
- Participation will last about 40 weeks and involve about 20 visits to the study research site
-
For more information about this trial, please visit ClinicalTrials.gov
